Table 1 Selected M. goodii reported human cases after Brown et al.
From: Mycobacterium goodii endocarditis following mitral valve ring annuloplasty
Infection type | Age | Sex | Comorbidities | Treatment | Microbial susceptibility |
|---|---|---|---|---|---|
Mitral valve endocarditis complicating ring annuloplasty | 67 | M | None | Mitral valve replacement, ciprofloxacin + TMP/SMX (6 months) | Susceptible to TMP/SMX, amikacin, doxycycline, ciprofloxacin, imipenem, linezolid Resistant to clarithromycin |
Prosthetic mitral valve endocarditis [8] | 76 | F | None mentioned | Mitral valve replacement, tigecycline + ciprofloxacin (2 weeks) doxycycline + ciprofloxacin (11 weeks) | Resistant to cefotaxime, erythromycin, clarithromycin |
Pacemaker site infection [9] | 23 | M | Partial AV canal defect repair at 5 years of age | Pacemaker retained, ofloxacin + amikacin (1 month), doxycycline (6 months) | Resistant to clarithromycin |
Pacemaker pocket infection [10] | 85 | M | Ischemic cardiomyopathy | Pacemaker replacement, TMP/SMX (8Â weeks) | Susceptible to TMP/SMX, minocycline, imipenem |
Pacemaker pocket and bloodstream infection [11] | 82 | M | None mentioned | Pacemaker removal, amikacin + minocycline | Resistant to clarithromycin, cefoxitin, clindamycin, vancomycin |
Pacemaker pocket infection [12] | 74 | F | Bicuspid aortic valve, hypothyroidism, diabetes mellitus, gastro-esophageal reflux disease, asthma | Pacemaker removal, ciprofloxacin + doxycycline (6 months) | Susceptible to amikacin, ciprofloxacin, doxycycline, imipenem, linezolid, tobramycin and trimethoprim/sulfamethoxazole Resistant to clarithromycin |
Ventriculo-peritoneal shunt infection [13] | 60 | F | Allergy to sulfa drugs | Ventriculoperitoneal shunt removal, imipenem + moxifloxacin (5 weeks), moxifloxacin monotherapy (3 additional months) | Resistant to azithromycin, clarithromycin |
Hernia mesh infection with abdominal wall abscess [14] | 65 | M | None mentioned | Mesh removal, TMP/SMX | Resistant to cefoxitin, clarithromycin |
Hernia mesh infection [15] | 64 | M | None mentioned | Patch removal. Antibacterial treatment not specified | Susceptible to ciprofloxacin, doxycycline and TMP/SMX |
Skin graft infection [16] | 6 | M | None mentioned | TMP/SMXÂ +Â linezolid (6Â months) | Resistant to clarithromycin, amoxicillin/clavulanate |
Prosthetic total knee joint infection [17] | 44 | M | Nicotine dependence, significant ethanol use | Removal of prosthesis, TMP/SMX (stopped after 1 week by patient), minocycline + ciprofloxacin (6 months) | Resistant to clindamycin |
Prosthetic total knee joint infection [15] | 75 | F | None mentioned | Prosthesis replaced | Susceptible to ciprofloxacin, doxycycline and TMP/SMX |
Prosthetic total hip joint infection [15] | 64 | M | None mentioned | Prosthesis replaced | Susceptible to ciprofloxacin, doxycycline and TMP/SMX |
Olecranon bursitis following corticosteroid injections [18] | 60 | M | Diabetes mellitus | Doxycycline + ciprofloxacin (10 weeks) | Resistant to clarithromycin |
Postcataract endophthalmitis [19] | 67 | M | None mentioned | Pars plana vitrectomy + lens removal, intravitreal amikacin × 2 doses | None reported |
Aspiration pneumonia [20] | 15 | F | Rickettsial infection | Laparoscopic Heller myotomy with fundoplication, ciprofloxacin + doxycycline (12 months) | Resistant to clarithromycin |
Complicated parapneumonic effusion [21] | 66 | M | None mentioned | None mentioned | None mentioned |